目次

Chapter- 1: Introduction
Study Goals and Objectives
Reasons for Doing This Study
Intended Audience
Scope of Report
What's New in this Report?
Information Sources
Methodology
Geographic Breakdown
Analyst's Credentials
BCC Custom Research
Related BCC Research Reports

Chapter- 2: Summary and Highlights
Highlights of the Market for CRISPR Technology
Table 0A : Global Market for CRISPR Technology, by End User, Through 2027
Figure 0A : Global Market for CRISPR Technology, by End User, 2019-2027
Table 0B : Global Market for CRISPR Technology, by Region, Through 2027
Figure 0B : Global Market for CRISPR Technology, by Region, 2019-2027

Chapter- 3: Market Overview
CRISPR: Genetic Editing
Components of CRISPR-Cas Systems
How CRISPR-Cas Works?
Advantage of the CRISPR-Cas9 System
Popularity of CRISPR Genome Editing
Pros of Genetic Editing
CRISPR Development Phases
Market Potential
Regulatory Framework
Porter's Five Forces Analysis of the Market for CRISPR Technology
Scientific Publications
Patent Analysis
Future of CRISPR
Market Drivers
Market Restraints
Market Challenges

Chapter- 4: Industry Structure
Commercial Therapeutics
Correcting Genetic Errors
Microbes
Healthier Food

Chapter- 5: Impact of COVID-19 on the Market for CRISPR Technology
Overview

Chapter- 6: Competitive Landscape
Overview
Competitive Scenario
Beam Therapeutics
CRISPR Therapeutics
Editas Medicine
Intellia Therapeutics
Growth Strategies

Chapter- 7: Global Market for CRISPR Technology by End User
Market Overview
Market Share and Forecast
Biotechnology and Pharmaceutical Companies
Academics and Government Research Institutes
Contract Research Organizations

Chapter- 8: Global Market for CRISPR Technology by Application
Market Share and Forecast
Drug Development
Agriculture
Diagnostics
Clinical Therapy
Others

Chapter- 9: Global Market for CRISPR Technology by Region
North America
Europe
Asia-Pacific
Rest of the World
Figure 28 : Snapshot of the Global Market for CRISPR Technology
Table 24 : Global Market for CRISPR Technology, by Region, Through 2027

Chapter- 10: Company Profiles
CARIBOU BIOSCIENCES
CRISPR THERAPEUTICS AG
DANAHER CORP.
EDITAS MEDICINE
GENSCRIPT
HERA BIOLABS
INTELLIA THERAPEUTICS INC.
LONZA GROUP LTD.
MAMMOTH BIOSCIENCES INC.
NEW ENGLAND BIOLABS INC.
ORIGENE TECHNOLOGIES
PERKINELMER
PRECISION BIOSCIENCES
SYNTHEGO
THERMO FISHER SCIENTIFIC
TOOLGEN INC.